Browsing Tag:Biogen

biogen-alzheimers-drug-and-the-new-battle-over-dementia-treatment
Aduhelm from BiogenSource: BiogenThe FDA approval of Biogen's Alzheimer's drug Aduhelm marked a milestone in Dr. Paul Aisen. The director of the Alzheimer's Therapeutic Research Institute at USC has focused on the treatment of neurodegenerative disease for the past three decades and in recent years has helped guide this particular drug through the various phases of clinical...
Continue reading
0 Comments
Share
chewy-biogen-snowflake-and-more
The signage can be seen ahead of Chewy's initial public offering on the New York Stock Exchange on June 14, 2019.Andrew Kelly | ReutersCheck out the companies that are making the headlines in midday trading.Snowflake - The cloud computing company's shares fell 3.3%. The company presented its financial targets at its Investor Day meeting on Thursday for...
Continue reading
0 Comments
Share
alzheimers-drug-is-bonanza-for-biogen-most-likely-at-taxpayer-expense
In addition to the US, Biogen has also asked regulators in Australia, Brazil, Canada, the European Union, Japan, and Switzerland to review the drug.US approval is a critical win for a company that has relied on Aduhelm to offset stalled or declining sales of its other products. Competitors introduced generics of Biogen's multiple sclerosis drug Tecfidera last year,...
Continue reading
0 Comments
Share